Stem Cell Banking
Cord Blood & Tissue
Stem Cell Packages
REPRODUCTIVE HEALTH
Immunogenetics
Genome Sequencing
Oncology
Screening
Health and Wellness
Learning Resources
Training service
Reproductive Health
Maternal Cell Contamination (MCC)
Reproductive Health Tests
Schedule Your Consultation Today
Take the first step toward personalized, non-invasive reproductive health insights.
Accurate Fetal Testing Begins with MCC Detection
Maternal cell contamination analysis plays a critical role in ensuring the accuracy of fetal genetic results by detecting the presence of maternal DNA in prenatal or miscarriage samples. Eliminating this interference allows for precise interpretation of fetal genetics for both diagnostic and investigative purposes.
Conditions Detected by MCC
01
Maternal DNA Interference
02
False-Negative Genetic Results
03
Sample Quality Assurance
04
Enhanced Genetic Accuracy
Confidence Starts with Clean Results
Greater Accuracy
Confirms that fetal DNA is isolated and uncontaminated for true diagnostic clarity through a reliable maternal cell contamination analysis.
Reliable Interpretation
Avoids misleading results that could impact critical clinical or emotional decisions, especially during sensitive prenatal investigations.
Streamlined Workflow
Ensures a smooth and verified testing process before advanced genetic analysis begins.
Peace of Mind
Know that your results are based on pure and verified fetal DNA, free from maternal interference.
How It Works
Simple Steps to Validate Sample Purity
Sample Submission
Submit miscarriage tissue, chorionic villi, or amniotic fluid samples for a maternal cell contamination blood test.
DNA Comparison
Maternal and fetal DNA profiles are compared to detect contamination levels.
Verified Reporting
Receive a clear report on contamination status, with expert recommendations for re-collection or next steps if needed.
Why Choose FSG?
01
Advanced Screening Tools
We use high-precision molecular techniques for maternal cell contamination testing, capable of detecting even low levels of maternal DNA.
02
Expert Validation
Every report is reviewed by our certified genetic specialists to ensure accuracy and trust.
03
Fast
Turnaround
Turnaround
Our streamlined process delivers results quickly—enabling timely decisions for further testing or intervention.
04
Accredited Lab
As the UAE’s first certified stem cell and genomics laboratory, we are the trusted choice for accurate maternal cell contamination tests in Dubai.
FAQ’s
Frequently Asked Questions!
We’re here to help. Explore answers or reach out to our team directly.
A maternal cell contamination test is used to determine whether maternal DNA is present in a fetal or miscarriage sample. This step is crucial to ensure that the results reflect only the fetal genetic material. At FSG, we conduct maternal cell contamination analysis to confirm sample purity before any further genetic evaluation.
The detection of fetal cells is typically performed through non-invasive prenatal testing (NIPT), which analyzes cell-free fetal DNA. In cases where accuracy is critical—such as post-miscarriage analysis or invasive sampling—a maternal cell contamination blood test can be recommended to ensure that the results are not affected by maternal DNA.
Maternal cell contamination in amniotic fluid refers to the unintended presence of maternal DNA in a sample intended for fetal analysis. This can compromise test results. A maternal cell contamination analysis helps identify such interference to ensure accurate interpretation of the fetal genome.
In the context of prenatal diagnostics, MCC (maternal cell contamination) in a blood test indicates the presence of maternal DNA that may distort the analysis of fetal DNA. A maternal cell contamination blood test is performed to detect and assess contamination levels, ensuring reliable and clinically valid genetic results.
Non-Invasive Prenatal Testing/Screening
Pre-Implantation Genetic Testing/Screening (PGT/PGS)
Male/Female Fertility
Rapid Prenatal & Pregnancy Loss
Maternal Cell Contamination (MCC)
Product of Conception (POC)
My HLA (Human Leucocyte Antigen)
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Low Pass Sequencing (1-3x Coverage)
Comprehensive Oncology Screening
Breast Cancer Screening (BRCA)
Cervical Cancer Screening
Prostate Cancer Screening
Heredity Cancer Panel
Leukemia Panel
Lymphoma Panel
Carrier Screening
Newborn Screening
Infectious Diseases Screening
Rare Diseases Screening
Consumer Genomics
Gut Metagenomics
Metagenomics
Personalized Medicine